Theravance Biopharma, Inc. Note Agreements
2 Contracts & Agreements
- Form of Note Purchase Agreement, dated February 21, 2020 by and among Theravance Biopharma R&D, Inc., Triple Royalty Sub II LLC, and the Purchasers (Filed With SEC on February 27, 2020)
- Form of Note Purchase Agreement, dated November 30, 2018 (Filed With SEC on December 3, 2018)
